Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of May 1, 2021
Q1 FY2021
As of Mar 18, 2021
Q3 FY2020
As of Nov 6, 2020
Q2 FY2020
As of Aug 7, 2020
Q1 FY2020
As of Mar 31, 2020
Q2 FY2020
As of Jun 5, 2020
Assets
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable, net of allowance for credit losses of $3,549 and $6,628, respectively
Income tax receivable
Related party receivables and prepaid expenses
Inventories, net
Prepaid expenses and other current assets
Assets of disposal group held for sale
Total current assets
Property, plant and equipment, net of accumulated depreciation of $218,877 and $213,142, respectively
Operating lease right-of-use assets, net
Goodwill
Intangible assets, net
Deferred income tax assets
Other noncurrent assets
Total assets
Liabilities and Stockholders' Deficit
Liabilities
Current liabilities
Current portion of long-term debt
Accounts payable
Related party payables
Income tax payable
Accrued liabilities
Accrued compensation and benefits
Accrued interest
Customer deposits
Deferred revenue
Obligation for claim payment
Current portion of finance lease liabilities
Current portion of operating lease liabilities
Liabilities of disposal group held for sale
Total current liabilities
Long-term debt, net of current maturities
Finance lease liabilities, net of current portion
Pension liabilities, net
Deferred income tax liabilities
Long-term income tax liabilities
Operating lease liabilities, net of current portion
Other long-term liabilities
Total liabilities
Stockholders' deficit
Common Stock, par value of $0.0001 per share; 1,600,000,000 shares authorized; 6,365,363 shares issued and outstanding at September 30, 2024 and 6,365,355 shares issued and outstanding at December 31, 2023
Preferred stock
Series A Preferred Stock
Total preferred stock
Additional paid in capital
Less: Common Stock held in treasury, at cost; 122,585 shares at June 30, 2022 and December 31, 2021
Less: Common Stock held in treasury, at cost; 0 shares at December 31, 2023 and 612 shares at December 31, 2022
Equity-based compensation
Accumulated deficit
Accumulated other comprehensive loss:
Foreign currency translation adjustment
Unrealized pension actuarial gains (losses), net of tax
Total accumulated other comprehensive loss
Total stockholders' deficit attributable to Exela Technologies, Inc.
Noncontrolling interest in XBP Europe
Total stockholders' deficit
Total liabilities and stockholders' deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support